In vitro evaluation of actively targetable superparamagnetic nanoparticles to the folate receptor positive cancer cells

Materials Science and Engineering C

Volumn 69, Issue , 2016, Pages 1147-1158

  Nasiri, Rozita ^a   Hamzehalipour Almaki, Javad ^a   Idris, Ani Binti ^a   Abdul Majid, Fadzilah Adibah ^a,d   Nasiri, Mahtab ^b   Salouti, Mojtaba ^c   Irfan, Muhammad ^a   Amini, Neda ^a   Marvibaigi, Mohsen ^a  

^a UNIVERSITI TEKNOLOGI MALAYSIA   (Malaysia)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

^c ISLAMIC AZAD UNIVERSITY   (Iran)

^d UNIVERSITI MALAYSIA TERENGGANU   (Malaysia)

Author keywords

Bioconjugation; Co precipitation; FAR + cancer cells; Iron oxide nanoparticles; Superparamagnetic; Targeting

Indexed keywords

BINS; BIOCOMPATIBILITY; CELL CULTURE; CHEMICAL STABILITY; CITRIC ACID; CYTOLOGY; DISEASES; IRON OXIDES; MEDICAL APPLICATIONS; METAL NANOPARTICLES; NANOPARTICLES; PRECIPITATION (CHEMICAL); SUPERPARAMAGNETISM;

BIO-CONJUGATION; CANCER CELLS; IRON OXIDE NANOPARTICLE; SUPERPARAMAGNETICS; TARGETING;

CELLS;

BIOMATERIAL; CITRIC ACID; DEXTRAN; FOLATE RECEPTOR; FOLIC ACID; MAGNETITE NANOPARTICLE; SUPERPARAMAGNETIC IRON OXIDE;

BLOOD CELL; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; HELA CELL LINE; HUMAN; INFRARED SPECTROSCOPY; METABOLISM; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; TUMOR CELL LINE; X RAY DIFFRACTION;

BIOCOMPATIBLE MATERIALS; BLOOD CELLS; CELL LINE, TUMOR; CELL SURVIVAL; CITRIC ACID; DEXTRANS; FOLATE RECEPTORS, GPI-ANCHORED; FOLIC ACID; HELA CELLS; HUMANS; MAGNETITE NANOPARTICLES; MICROSCOPY, ELECTRON, SCANNING; MICROSCOPY, ELECTRON, TRANSMISSION; PARTICLE SIZE; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; X-RAY DIFFRACTION;

EID: 84981727581     PISSN: 09284931     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.msec.2016.07.076     Document Type: Article

References (68)

1. [1] Hu, S., Arellano, M., Boontheung, P., Wang, J., Zhou, H., Jiang, J., Elashoff, D., Wei, R., Loo, J.A., Wong, D.T., Salivary proteomics for oral cancer biomarker discovery. Clin. Cancer Res. 14:19 (2008), 6246–6252.
2. [2] Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., Dirks, P.B., Identification of human brain tumour initiating cells. Nature 432:7015 (2004), 396–401.
3. [3] Laurent, S., Forge, D., Port, M., Roch, A., Robic, C., Vander Elst, L., Muller, R.N., Magnetic iron oxide nanoparticles: synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem. Rev. 108:6 (Jun. 2008), 2064–2110.
4. [4] Fang, C., Zhang, M., Multifunctional magnetic nanoparticles for medical imaging applications. J. Mater. Chem. 19:35 (2009), 6258–6266.
5. [5] McCarthy, J.R., Weissleder, R., Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv. Drug Deliv. Rev. 60:11 (2008), 1241–1251.
6. [6] Woo, K., Hong, J., Choi, S., Lee, H.-W., Ahn, J.-P., Kim, C.S., Lee, S.W., Easy synthesis and magnetic properties of iron oxide nanoparticles. Chem. Mater. 16:14 (2004), 2814–2818.
7. [7] Wu, W., He, Q., Jiang, C., Magnetic iron oxide nanoparticles: synthesis and surface functionalization strategies. ChemInform, 40(24), 2009, i.
8. [8] Li, L., Mak, K.Y., Leung, C.W., Chan, K.Y., Chan, W.K., Zhong, W., Pong, P.W.T., Effect of synthesis conditions on the properties of citric-acid coated iron oxide nanoparticles. Microelectron. Eng. 110 (2013), 329–334.
9. [9] Wahajuddin, S.A., Superparamagnetic iron oxide nanoparticles: magnetic nanoplatforms as drug carriers. Int. J. Nanomedicine, 7, 2012, 3445.
10. [10] Neuberger, T., Schöpf, B., Hofmann, H., Hofmann, M., Von Rechenberg, B., Superparamagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J. Magn. Magn. Mater. 293:1 (2005), 483–496.
11. [11] Bean, C.P., Livingston, J.D., Superparamagnetism. J. Appl. Phys. 30:4 (1959), S120–S129.
12. [12] Mahmoudi, M., Simchi, A., Imani, M., Recent advances in surface engineering of superparamagnetic iron oxide nanoparticles for biomedical applications. J. Iran. Chem. Soc. 7:2 (2010), S1–S27.
13. [13] Jain, T.K., Morales, M.A., Sahoo, S.K., Leslie-Pelecky, D.L., Labhasetwar, V., Iron oxide nanoparticles for sustained delivery of anticancer agents. Mol. Pharm. 2:3 (2005), 194–205.
14. [14] Vayssieres, L., Chanéac, C., Tronc, E., Jolivet, J.P., Size tailoring of magnetite particles formed by aqueous precipitation: an example of thermodynamic stability of nanometric oxide particles. J. Colloid Interface Sci. 205:2 (1998), 205–212.
15. 4 nanoparticles: conjugation and release of doxorubicin for therapeutic applications. J. Magn. Magn. Mater. 323:2 (2011), 237–243.
16. [16] Lapresta-Fernández, A., Doussineau, T., Dutz, S., Steiniger, F., Moro, A.J., Mohr, G.J., Magnetic and fluorescent core–shell nanoparticles for ratiometric pH sensing. Nanotechnology, 22(41), 2011, 415501.
17. [17] Liu, C., Huang, P.M., Atomic force microscopy and surface characteristics of iron oxides formed in citrate solutions. Soil Sci. Soc. Am. J. 63:1 (1999), 65–72.
18. [18] Lee, J.-H., Huh, Y.-M., Jun, Y., Seo, J., Jang, J., Song, H.-T., Kim, S., Cho, E.-J., Yoon, H.-G., Suh, J.-S., Artificially engineered magnetic nanoparticles for ultra-sensitive molecular imaging. Nat. Med. 13:1 (2007), 95–99.
19. [19] Goya, G.F., Grazu, V., Ibarra, M.R., Magnetic nanoparticles for cancer therapy. Curr. Nanosci. 4:1 (2008), 1–16.
20. [20] Choi, H., Choi, S.R., Zhou, R., Kung, H.F., Chen, I.-W., Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery 1. Acad. Radiol. 11:9 (2004), 996–1004.
21. [21] Artemov, D., Molecular magnetic resonance imaging with targeted contrast agents. J. Cell. Biochem. 90:3 (2003), 518–524.
22. [22] Leuschner, C., Kumar, C.S.S.R., Hansel, W., Soboyejo, W., Zhou, J., Hormes, J., LHRH-conjugated magnetic iron oxide nanoparticles for detection of breast cancer metastases. Breast Cancer Res. Treat. 99:2 (Sep. 2006), 163–176.
23. [23] Zhang, Y., Kohler, N., Zhang, M., Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake. Biomaterials 23:7 (2002), 1553–1561.
24. [24] Garin-Chesa, P., Campbell, I., Saigo, P.E., Lewis, J.L. Jr., Old, L.J., Rettig, W.J., Trophoblast and ovarian cancer antigen LK26. Sensitivity and specificity in immunopathology and molecular identification as a folate-binding protein. Am. J. Pathol., 142(2), 1993, 557.
25. [25] Ross, J.F., Chaudhuri, P.K., Ratnam, M., Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 73:9 (1994), 2432–2443.
26. [26] Weitman, S.D., Lark, R.H., Coney, L.R., Fort, D.W., Frasca, V., Zurawski, V.R., Kamen, B.A., Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues. Cancer Res. 52:12 (1992), 3396–3401.
27. [27] Barz, M., Canal, F., Koynov, K., Zentel, R., Vicent, M.J., Synthesis and in vitro evaluation of defined HPMA folate conjugates: influence of aggregation on folate receptor (FR) mediated cellular uptake. Biomacromolecules 11:9 (2010), 2274–2282.
28. [28] Massart, R., Preparation of aqueous magnetic liquids in alkaline and acidic media. IEEE Trans. Magn., 1981, 1247–1248.
29. [29] Idris, A., Hassan, N., Suriani, N., Ismail, M., Misran, E., Mohd, N., Ngomsik, A., Bee, A., Photocatalytic magnetic separable beads for chromium (VI) reduction. Water Res. 44:6 (2010), 1683–1688.
30. [30] Idris, A., Ismail, N.S.M., Hassan, N., Misran, E., Ngomsik, A.-F., Synthesis of magnetic alginate beads based on maghemite nanoparticles for Pb(II) removal in aqueous solution. J. Ind. Eng. Chem. 18:5 (Sep. 2012), 1582–1589.
31. [31] Patel, N., Davies, M.C., Hartshorne, M., Heaton, R.J., Roberts, C.J., Tendler, S.J.B., Williams, P.M., Immobilization of protein molecules onto homogeneous and mixed carboxylate-terminated self-assembled monolayers. Langmuir 13:24 (1997), 6485–6490.
32. [32] Wang, H., Castner, D.G., Ratner, B.D., Jiang, S., Probing the orientation of surface-immobilized immunoglobulin G by time-of-flight secondary ion mass spectrometry. Langmuir 20:5 (2004), 1877–1887.
33. [33] Grüttner, C., Müller, K., Teller, J., Westphal, F., Foreman, A., Ivkov, R., Synthesis and antibody conjugation of magnetic nanoparticles with improved specific power absorption rates for alternating magnetic field cancer therapy. J. Magn. Magn. Mater. 311:1 (2007), 181–186.
34. [34] Munnier, E., Cohen-Jonathan, S., Hervé, K., Linassier, C., Soucé, M., Dubois, P., Chourpa, I., Doxorubicin delivered to MCF-7 cancer cells by superparamagnetic iron oxide nanoparticles: effects on subcellular distribution and cytotoxicity. J. Nanopart. Res. 13:3 (Oct. 2010), 959–971.
35. [35] Saraswathy, A., Nazeer, S.S., Nimi, N., Arumugam, S., Shenoy, S.J., Jayasree, R.S., Synthesis and characterization of dextran stabilized superparamagnetic iron oxide nanoparticles for in vivo MR imaging of liver fibrosis. Carbohydr. Polym. 101 (2014), 760–768.
36. [36] Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays., 65, 1983, 55–63.
37. [37] Saul, J.M., Annapragada, A., Natarajan, J.V., Bellamkonda, R.V., Controlled targeting of liposomal doxorubicin via the folate receptor in vitro. J. Control. Release 92:1 (2003), 49–67.
38. [38] Matei, E., Predescu, A., Vasile, E., Properties of magnetic iron oxides used as materials for wastewater treatment. J. Phys. Conf. Ser., 304, Jul. 2011, 012022.
39. 4 hollow and core-shell spheres. J. Mater. Chem. 20:9 (2010), 1799–1805.
40. [40] Kumar, A., Gupta, M., Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications., 26, 2005, 3995–4021.
41. [41] Purushotham, S., Ramanujan, R.V., Thermoresponsive magnetic composite nanomaterials for multimodal cancer therapy. Acta Biomater. 6:2 (Feb. 2010), 502–510.
42. [42] Haidary, S.M., Córcoles, E.P., Ali, N.K., Folic acid delivery device based on porous silicon nanoparticles synthesized by electrochemical etching., 8, 2013, 9956–9966.
43. [43] Alexis, F., Pridgen, E., Molnar, L.K., Farokhzad, O.C., Factors affecting the clearance and biodistribution of polymeric nanoparticles., 5(4), 2008, 505–515 (Reviews).
44. [44] Manuscript, A., Clearance properties of nano-sized particles and molecules as imaging agents: considerations and caveats. Nanomedicine (Lond) 3:5 (2012), 703–717.
45. [45] Almaki, J.H., Nasiri, R., Idris, A., Majid, F.A.A., Salouti, M., Wong, T.S., Dabagh, S., Marvibaigi, M., Amini, N., Synthesis, characterization and in vitro evaluation of exquisite targeting SPIONs–PEG–HER in HER2 + human breast cancer cells. Nanotechnology, 27(10), 2016, 105601.
46. [46] Juang, T.-Y., Kan, S.-J., Chen, Y.-Y., Tsai, Y.-L., Lin, M.-G., Lin, L.-L., Surface-functionalized hyperbranched poly(amido acid) magnetic nanocarriers for covalent immobilization of a bacterial γ-glutamyltranspeptidase. Molecules 19:4 (Jan. 2014), 4997–5012.
47. [47] Kumar, R., Development and Potential Applications of Nanomaterials for Arsenic Removal From Contaminated Groundwater. March 2011.
48. 4 nanoparticles: conjugation and release of doxorubicin for therapeutic applications. J. Magn. Magn. Mater. 323:2 (Jan. 2011), 237–243.
49. [49] Airinei, A., Citric-acid – coated magnetite nanoparticles for biological applications., 121, 2006, 117–121.
50. [50] Bora, D.K., Deb, P., Fatty acid binding domain mediated conjugation of ultrafine magnetic nanoparticles with albumin protein. Nanoscale Res. Lett. 4:2 (Jan. 2008), 138–143.
51. 4, folic acid and doxorubicin as dual-targeted drug nanocarrier. Colloids Surf. B: Biointerfaces 106 (2013), 60–65.
52. [52] Ahmadi, M.K., Vossoughi, M., Immobilization of -chymotrypsin on the surface of magnetic/gold core/shell nanoparticles., 2013, 2013.
53. [53] Mansoori, G.A., Brandenburg, K.S., Shakeri-zadeh, A., A comparative study of two folate-conjugated gold nanoparticles for cancer nanotechnology applications., 7, 2010, 1911–1928.
54. [54] Wang, T., Wu, H., Wang, W., Lin, F., Lou, P., Shieh, M., Young, T., The development of magnetic degradable DP-Bioglass for hyperthermia cancer therapy. J. Biomed. Mater. Res. Part A 83:3 (2007), 828–837.
55. [55] Tomitaka, A., Koshi, T., Hatsugai, S., Yamada, T., Takemura, Y., Magnetic characterization of surface-coated magnetic nanoparticles for biomedical application. J. Magn. Magn. Mater. 323:10 (2011), 1398–1403.
56. [56] Idris, A., Suriani, N., Ismail, M., Hassan, N., Misran, E., Ngomsik, A., Journal of industrial and engineering chemistry synthesis of magnetic alginate beads based on maghemite nanoparticles for Pb (II) removal in aqueous solution. J. Ind. Eng. Chem. 18:5 (2012), 1582–1589.
57. [57] Brusentsov, N.A., Gogosov, V.V., Brusentsova, T.N., Sergeev, A.V., Jurchenko, N.Y., Kuznetsov, A.A., Kuznetsov, O.A., Shumakov, L.I., Evaluation of ferromagnetic fluids and suspensions for the site-specific radiofrequency-induced hyperthermia of MX11 sarcoma cells in vitro. J. Magn. Magn. Mater. 225:1 (2001), 113–117.
58. [58] Xu, C., Xu, K., Gu, H., Zhong, X., Guo, Z., Zheng, R., Zhang, X., Xu, B., Nitrilotriacetic acid-modified magnetic nanoparticles as a general agent to bind histidine-tagged proteins. J. Am. Chem. Soc. 126:11 (2004), 3392–3393.
59. [59] Gokce, G., Citil, M., Gunes, V., Atalan, G., Effect of time delay and storage temperature on blood gas and acid–base values of bovine venous blood. Res. Vet. Sci. 76:2 (2004), 121–127.
60. [60] Fura, A., Harper, T.W., Zhang, H., Fung, L., Shyu, W.C., Shift in pH of biological fluids during storage and processing: effect on bioanalysis. J. Pharm. Biomed. Anal. 32:3 (2003), 513–522.
61. [61] Jayalekshmi, A.C., Victor, S.P., Sharma, C.P., Magnetic and degradable polymer/bioactive glass composite nanoparticles for biomedical applications. Colloids Surfaces B Biointerfaces 101 (2013), 196–204.
62. [62] Durgadas, C.V., Sreenivasan, K., Sharma, C.P., Bright blue emitting CuSe/ZnS/silica core/shell/shell quantum dots and their biocompatibility. Biomaterials 33:27 (2012), 6420–6429.
63. [63] Szekeres, M., Tóth, I.Y., Illés, E., Hajdú, A., Zupkó, I., Chemical and colloidal stability of carboxylated core-shell magnetite nanoparticles designed for biomedical applications., 0067, 2013, 14550–14574.
64. [64] Ali, A.S.G., Reza, M.A., Eshghi, H., Sazgarnia, A., Montazerabadi, A.R., Cancerous Cells Targeting and Destruction Using Folate Conjugated Gold Nanoparticles. 2010.
65. [65] Nateghian, N., Goodarzi, N., Amini, M., Atyabi, F., Khorramizadeh, M.R., Dinarvand, R., Biotin/folate-decorated human serum albumin nanoparticles of docetaxel: comparison of chemically conjugated nanostructures and physically loaded nanoparticles for targeting of breast cancer. Chem. Biol. Drug Des., 2015.
66. [66] Varshosaz, J., Ghasemi, S., Behdadfar, B., Use of magnetic folate-dextran-retinoic acid micelles for dual targeting of doxorubicin in breast cancer., 2013, 2013.
67. [67] Berry, C.C., Wells, S., Charles, S., Curtis, A.S.G., Dextran and albumin derivatised iron oxide nanoparticles: influence on fibroblasts in vitro. Biomaterials 24:25 (2003), 4551–4557.
68. 3 nanoparticles on human melanoma cells. J. Nanosci. Nanotechnol. 8:5 (2008), 2385–2391.